A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies. (Q54675660)
Jump to navigation
Jump to search
scientific article published on 8 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies. |
scientific article published on 8 May 2010 |
Statements
A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies. (English)
Benoit You
Anthony Brade
Joao M Magalhaes
Lillian L Siu
Amit Oza
Sonya Lovell
Lisa Wang
Leonardo V Nicacio
Eric X Chen
8 May 2010
29
5
996-1003
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference